Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 7, Number 9, September 2015, pages 700-705


Comparison of Energy Expenditure and Oxygen Consumption of Spontaneous Breathing Trial Conducted With and Without Automatic Tube Compensation

Figures

Figure 1.
Figure 1. Experimental design used throughout the study.
Figure 2.
Figure 2. Box plot of VO2, EE, VCO2, and RQ at baseline, with and without ATC. The diamonds are atypical values (outliers).

Tables

Table 1. Study Participants Demographics
 
VariablesValues
SD: standard deviation; APACHE II: Acute Physiology and Chronic Health Evaluation II; SAPS 3: Simplified Acute Physiology Score 3; ICU: intensive care unit; MV: mechanical ventilation; ETT: endotracheal tube or tracheostomy; ARF: acute respiratory failure; COPD: chronic obstructive pulmonary disease.
Gender
  Male, n (%)18 (51)
  Female, n (%)17 (49)
Age (years) (mean ± SD)61.4 ± 16.1
APACHE II (mean ± SD)24.6 ± 8.4
SAPS 3 (mean ± SD)67.7 ± 22
ICU mortality, n (%)6 (15)
Hospital mortality, n (%)17 (42.5)
Length of ICU stay (mean ± SD)14.1 ± 8.2
Length of hospital stay (mean ± SD)78 ± 70.71
Airway resistance at baseline (cm H2O/L/s)9.02 ± 2.35
ETT size (mm)7.85 ± 0.49
Reason to initiate MV
  ARF, n (%)24 (68%)
  Septic shock, n (%)7 (20%)
  COPD, n (%)2 (6%)
  Hepatic encephalopathy, n (%)1 (3%)
  Cerebrovascular accident, n (%)1 (3%)
Cause of ARF
  Pneumonia, n (%)11 (46%)
  Post-operative, n (%)7 (29%)
  Acute pulmonary edema, n (%)3 (12.5%)
  Sepsis, n (%)2 (8.4%)
  Cardiac arrest, n (%)1 (4.1%)
Diagnosis upon admission
  Septic shock, n (%)11 (31%)
  Respiratory, n (%)11 (31%)
  Post-operative, n (%)9 (26%)
  Cerebrovascular accident, n (%)1 (3%)
  Others, n (%)3 (9)

 

Table 2. Estimated Values for the Differences of T1 and T2, G1 and G2, and P1 and P2
 
VariablesEstimated value T1-T295% confidence intervalP valueEstimated value G1-G295% confidence intervalP valueEstimated value P1-P295% confidence intervalP value
T1: treatment 1 with ATC; T2: treatment 2 without ATC; G1: group 1; G2: group 2; P1: period 1; P2: period 2; VO2: oxygen consumption; EE: energy expenditure; VCO2: carbon dioxide production; RQ: respiratory quotient; Vt: tidal volume; Rr: respiratory rate; RSBI: rapid shallow breathing index; P0.1: airway occlusion pressure 100 ms after onset of inspiratory flow; HR: heart rate; MAP: mean arterial pressure; SPO2: peripheral oxygen saturation.
VO2 (mL/kg/min)-1.6-4.36 to 1.070.235.4-26.44 to 37.430.73-3.5-6.25 to -0.820.01
EE (kcal/day)-5.4-21.67 to 10.790.50034.0-163.79 to 231.930.728-22.8-39.04 to -6.580.007
VCO2 (mL/kg/min)0.3-2.49 to 3.110.822.1-15.30 to 19.640.821.0-3.86 to 1.740.45
RQ0.004-0.01 to 0.020.63-0.007-0.11 to 0.090.880.0230 to 0.040.02
Peak pressure (cm H2O)2.001.39 to 2.620.00010.55-0.93 to 2.030.45550.35-0.25 to 0.970.2446
Vt (mL)13.32-30.65 to 57.300.541524.20-89.14 to 137.560.666817.27-26.70 to 61.240.4296
Rr (bpm)0.34-0.87 to 1.560.56881.26-2.49 to 5.020.4993-0.76-1.98 to 0.440.2080
RSBI (bpm/L)1.17-4.11 to 6.460.65318.99-28.32 to 46.310.6268-3.77-9.06 to 1.510.1558
P0.1 (cm H2O)-0.49-0.84 to -0.140.00730.14-1.21 to 1.500.8276-0.39-0.75 to -0.040.0279
HR (beats per min)-1.84-3.65 to -0.0480.0445-1.38-9.25 to 12.020.7921-1.41-3.22 to 12.020.1176
MAP (mm Hg)-0.57-3.14 to 2.000.6526-7.74-16.89 to 1.400.09420.57-16.89 to 1.400.6510
SpO2 (%)-0.11-0.64 to 0.410.6644-0.63-1.98 to 0.710.34160.26-0.27 to 0.790.3235